Composition, form of production and packaging
? The tablets covered with a shell (sugar) of black color, oval, with a white inscription "Unikem" on one side.
fungal diastase 20 mg
papain 30 mg
simethicone 50 mg
activated carbon 75 mg
nicotinamide 25 mg
Auxiliary substances: microcrystalline cellulose, lactose, acacia powder, calcium hydrophosphate, gelatin, talc, magnesium stearate, sodium carmellose, shellac, sucrose, titanium dioxide, castor oil, calcium carbonate, wood charcoal, sodium benzoate, wax, carnauba wax.
10 pieces. - Strips (2) - packs of cardboard.
10 pieces. - Strips (10) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2005.
Digestive enzyme preparation with a component that reduces flatulence.
Papain and fungal diastase are digestive enzymes that facilitate the digestion and assimilation of proteins, fats and carbohydrates in the body.
Simethicone hampers formation and promotes the destruction of gas bubbles, facilitates the removal of gases from the intestine, thereby reducing bloating, nausea, pain and discomfort caused by flatulence.
Activated carbon adsorbs gases and toxins from digestive disorders.
Nicotinamide (vitamin PP) normalizes the motility of the gastrointestinal tract.
The therapeutic effect of the drug is the combined effect of its components, so it is not possible to carry out pharmacokinetic studies.
- as part of complex therapy of conditions accompanied by impairment of the exocrine function of the pancreas (chronic pancreatitis, liver disease);
-meteorism (including post-operative period), feeling of stomach overflow, nausea, eructation due to unusual food or overeating.
The drug is administered orally 1 tablet. 1-2 times / day after eating.
Possible: allergic reactions, redness of the skin (especially the face and neck).
- Acute pancreatitis;
acute gastrointestinal diseases;
-increased sensitivity to the components of the drug.
PREGNANCY AND LACTATION
Caution should be given to the drug during pregnancy and lactation (breastfeeding).
The patient should be informed that in case of deterioration of the state of health or the occurrence of side effects, you should consult a doctor.
There is no information about an overdose of Unienzyme with MPS.
Drug interaction of the drug Unienzyme with MPS is not described.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a protected from moisture place at a temperature of no higher than 25 В° C.